SPONSOR
Guangdong Association of Clinical Trials
Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: Lung Cancer (Non-Small Cell)Small-cell Lung CancerNSCLC (Non-small Cell Lung Cancer)MRDII-IIIB StagesAdjuvant Immunotherapy
Guangdong Association of Clinical Trials is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Lung Cancer (Non-Small Cell), Small-cell Lung Cancer, NSCLC (Non-small Cell Lung Cancer), MRD.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Guangdong Association of Clinical Trials
How many clinical trials has Guangdong Association of Clinical Trials sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Guangdong Association of Clinical Trials, of which 3 are actively recruiting participants. These trials cover conditions including Lung Cancer (Non-Small Cell), Small-cell Lung Cancer, NSCLC (Non-small Cell Lung Cancer). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Guangdong Association of Clinical Trials research focus on?
Guangdong Association of Clinical Trials clinical trials span Lung Cancer (Non-Small Cell), Small-cell Lung Cancer, NSCLC (Non-small Cell Lung Cancer), MRD, II-IIIB Stages, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Guangdong Association of Clinical Trials clinical trial?
To participate in a Guangdong Association of Clinical Trials trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Guangdong Association of Clinical Trials trials with current recruitment status updated daily.
Clinical Trials by Guangdong Association of Clinical Trials
NCT07198841 Phase 2
Recruiting
IBI351 Plus Cetuximab β in Untreated Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
Lung Cancer (Non-Small Cell)
NCT05957510 Phase 2
Recruiting
Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment
Small-cell Lung Cancer
NCT07120698 Phase 2
Recruiting
Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)
NSCLC (Non-small Cell Lung Cancer)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology